Clinical Trial Update: A Trial to Assess the Efficacy and Safety of SPM 927 (Lacosamide) in Subjects With Painful Distal Diabetic Neuropathy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy and safety of lacosamide (SPM 927) for painful distal diabetic neuropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuropathy

Drugs mentioned

• Vimpat (lacosamide)

Snippet

Sponsor: UCB Pharma | Conditions: Diabetic Neuropathy | Phase 3 | Status: COMPLETED